Skip to main content
. 2020 May 25;15:124. doi: 10.1186/s13023-020-01407-7

Table 2.

Latency in phenylketonuria patients and in controls

Study participants Reciprocal Latency (horizontally) Latency (horizontally)
PKU all (n = 19)
 Phenylalanine concentrations above age-related therapeutic ranges (*) (n = 10) 5.291/s (SD 0.99) 189 ms
 Phenylalanine concentrations within age-related therapeutic ranges (n = 9) 5.75 1/s (SD 1.05) 180 ms
Controls (n = 75) 5.65 1/s (SD 1.05) 177 ms

*: 238.4 μmol/l (64%) higher in comparison to the maximal age adjusted reference